For Incyte, XVIVO developed a chaptered animation program on the JAK signaling pathway. Janus kinases (JAK) are enzymes that mediate signaling of several important drivers of myeloproliferative neoplasms (MPNs), other hematological malignancies, and inflammatory diseases. This animation focuses on four JAK enzymes: JAK1, 2, 3 and TYK2. Aberrant activation of the JAK-STAT pathway has been documented in a variety of cancers. This clip illustrates normal JAK pathway activation and the associated downstream signaling.
Intuniv Marketing, Shire LLC.
I have had the pleasure of working closely with the XVIVO team for the past year and half as we prepared for launch. They have contributed to building a sound foundation for communicating our clinical messaging across multiple mediums and channels. XVIVO’s scientific rigor and technical expertise exceed any I have seen within the industry. The XVIVO team consists of highly professional engaging personnel that have mastered their respective areas of work. XVIVO are fun and engaging partners. The products that XVIVO consistently delivered elevated the power of our story.